Study type: In vivo/preclinical · Status: Verified against declared source
The Role of Cerebrolysin in Promoting Axonal Regeneration and Functional Recovery after Peripheral Nerve Injury: A Focus on Macrophage Activation
2025
Study scale: Peripheral nerve injuries (PNIs) affect more than 90,000 individuals annually, representing a significant global health concern.
Abstract only: Open source record
Product or molecular entity relationships
- Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Peripheral nerve injuries (PNIs) affect more than 90,000 individuals annually, representing a significant global health concern.
Methods
After peripheral nerve injury, Schwann cells (SCs) and neurons undergo regenerative adaptations.
Scale or participants
Peripheral nerve injuries (PNIs) affect more than 90,000 individuals annually, representing a significant global health concern.
Key findings
Results demonstrated that Cerebrolysin, particularly at 5 mg/kg, significantly improved SFI scores and thermal paw withdrawal latency compared to the control group, indicating enhanced functional recovery.
Limitations and uncertainty
Peripheral nerve injuries (PNIs) affect more than 90,000 individuals annually, representing a significant global health concern.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.